Jirawat Swangsri

Dr. Jirawat Swangsri


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 November 2024 in Surgery in Practice and Science
Verified
Journal Article
Open access
TPThammawat Parakonthun
Thammawat Parakonthun
GGGritin Gonggetyai
Gritin Gonggetyai
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
TSTharathorn Suwatthanarak
Tharathorn Suwatthanarak
TTThikhamporn Tawantanakorn
Thikhamporn Tawantanakorn
AMAsada Methasate
Asada Methasate
The enhanced recovery after surgery (ERAS) protocol has been proven to accelerate recovery without increasing morbidity, but few data are available from developing countries. We aimed to demonstrate the correlation between compliance with the ERAS protocol and short-term outcomes in upper gastrointestinal (UGI) surgery. Patients that underwent esophageal and gastric surgeries during March 2019 to June 2021 were prospectively enrolled in this nonrandomized cohort study. The ERAS protocol was applied based on patient-doctor agreement. Patients were categorized into conventional care (CC), moderate-compliance (MC), and high-compliance (HC) groups. Short-term outcomes including gastrointestinal (GI) function recovery, length of hospital stay (LOS), postoperative complications and mortality rate were compared. 158 patients were enrolled: 58 in the CC, 33 in the MC, and 67 in the HC group. The HC group demonstrated reduced time to tolerate oral diet (8 vs 7 vs 3 days; p = 0.034), recovery of GI function (72 vs 96 vs 61 h; p = 0.001) and median LOS (12.5 vs 10 vs 6 days; p < 0.001). Postoperative overall (p = 0.08) and major complications (p = 0.09) were not significantly different. Non-surgical complications were lower in the HC group (31.0 % vs 54.5 % vs 25.4 %; p = 0.013). The 28-day readmission rate was not different (8.6 % vs 3.0 % vs 1.5 %; p = 0.14). The 30-day postoperative mortality was not different (0 % vs 3.1 % vs 0 %; p = 0.15), but the 6-month mortality rate was significantly lower in the HC group (13.8 % vs 15.2 % vs 0 %; p < 0.001). The level of compliance with the ERAS protocol is associated with improved short-term postoperative outcome in UGI surgery. High compliance patients recovered faster, were discharged sooner, and had better 6-month survival.

16 October 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
AMAsada Methasate
Asada Methasate
ASAkarawin Sirimongkol
Akarawin Sirimongkol
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
JSJirawat Swangsri
Jirawat Swangsri
TPThammawat Parakonthun
Thammawat Parakonthun
Background/Objectives: To identify independent predictors of free peritoneal cancer cells (FPCC), and to investigate survival outcomes relative to peritoneal cytology status among patients underwent intended curative gastrectomy for adenocarcinoma of stomach or esophagogastric junction. Methods: Medical record of patients underwent radical surgery during January 2005-December 2020 were retrospectively reviewed. Clinical data and cytology results were evaluated. Multivariate Cox regression analysis was used to identify independent predictors of FPCC. Kaplan-Meier survival analysis was used to estimate disease recurrence and survival outcomes. Results: Of the 349 enrolled patients, 188 (53.8%) had negative cytology, 32 (9.2%) had positive cytology, and 129 (36.9%) had atypical cells in peritoneal cytology. Multivariate analysis revealed poor differentiation (adjusted odds ratio [aOR]: 2.63, 95% confidence interval [95%CI]: 1.04-6.82; p=0.015), pT4 (aOR: 4.62, 95%CI: 1.28-14.34; p=0.018), pN3 (aOR: 4.13, 95%CI: 1.14-15.03; p=0.031), and metastatic lymph node ratio >0.40 (aOR: 6.49, 95%CI: 1.44-29.14; p=0.015) as independent predictors of FPCC. Median survival duration of patients with negative, positive, and atypical cell cytology was 34.1, 13.1, and 28.7 months, respectively (p<0.001). 5-year OS was 27.2%, 8.3%, and 25.3%, respectively (p<0.001). 3-year DFS was 17.8%, 0.0%, and 17.4%, respectively (p<0.001). Median time to disease recurrence was 20.5, 4.9, and 11.3 months, respectively (p0.40 are independent predictors of FPCC. The presence of FPCC was significantly associated with poor survival and disease recurrence outcomes.

10 November 2025 in Surgeries
Verified
Journal Article
Open access
PDF file
AMAsada Methasate
Asada Methasate
ASAkarawin Sirimongkol
Akarawin Sirimongkol
CNChawisa Nampoolsuksan
Chawisa Nampoolsuksan
JSJirawat Swangsri
Jirawat Swangsri
TPThammawat Parakonthun
Thammawat Parakonthun
Background/Objectives: To identify independent predictors of free peritoneal cancer cells (FPCC), and to investigate survival outcomes relative to peritoneal cytology status among patients who underwent intended curative gastrectomy for adenocarcinoma of the stomach or esophagogastric junction. Methods: Medical records of patients who underwent radical surgery between January 2005 and December 2020 were retrospectively reviewed. Clinical data and cytology results were evaluated. Multivariate Cox regression analysis was used to identify independent predictors of FPCC. Kaplan–Meier survival analysis was used to estimate disease recurrence and survival outcomes. Results: Out of the 349 enrolled patients, 188 (53.8%) had negative cytology, 32 (9.2%) were positive, and 129 (36.9%) showed atypical cells in peritoneal cytology. Poor differentiation (adjusted odds ratio [aOR]: 2.63, 95% confidence interval [95%CI]: 1.04–6.82; p = 0.015), pT4 (aOR: 4.62, 95%CI: 1.28–14.34; p = 0.018), pN3 (aOR: 4.13, 95%CI: 1.14–15.03; p = 0.031), and metastatic lymph node ratio >0.40 (aOR: 6.49, 95%CI: 1.44–29.14; p = 0.015) were independent predictors of FPCC. Median overall survival was 34.1 months in the negative group, 13.1 months in the positive group, and 28.7 months in the atypical cell group (p < 0.001). Median time to disease recurrence was 20.5, 4.9, and 11.3 months, respectively (p < 0.001). Survival and recurrence outcomes in the atypical cell group were comparable to those with negative cytology. Conclusions: Poorly differentiated histology, pT4, pN3, and metastatic lymph node ratio >0.40 are independent predictors of FPCC, which is significantly associated with poor survival and disease recurrence outcomes. These findings suggest that high-risk patients may benefit from routine peritoneal cytologic screening during surgery to improve risk stratification and guide postoperative treatment planning.